What Researchers Did
This review examined the pathophysiology of altitude mountain sickness (AMS) and proposed a comprehensive management approach, including hyperbaric oxygenation, for tourist populations.
What They Found
Researchers found that conventional AMS prevention relies on acclimatization, while management often involves medication, oxygen, or minor recompression at 1524-2438 meters altitude. They proposed that hyperbaric oxygenation (HBO2) in clinical chambers, capable of recompression to 3 atmospheres absolute (ATA), could effectively treat high-altitude induced hypoxaemia, building on protocols developed for the US military and NASA.
What This Means for Canadian Patients
Canadian patients traveling to high-altitude regions should be aware of altitude mountain sickness (AMS) symptoms and the importance of acclimatization. For severe cases, advanced treatments like hyperbaric oxygenation (HBO2) may offer a more effective solution than conventional methods, though access to such specialized facilities might vary.
Canadian Relevance
This review has no direct Canadian connection.
Study Limitations
As a review, this study proposes a management approach without presenting new empirical data or clinical trial results to validate its comprehensive strategy.